Analysed FORTRESS BIOTECH INC - FBIO 9 3/8 PERP (FBIOP:NASDAQ) News Sources
Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights
25-03-2026
yahoo.com
Fortress Biotech’s Subsidiary Cyprium Therapeutics Closes Sale of Rare Pediatric Disease Priority Review Voucher for $205 Million
30-03-2026
yahoo.com
Fortress Biotech Reports 2025 Financial Results and Recent Corporate Highlights
31-03-2026
yahoo.com
Fortress Biotech to Participate in the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference
04-05-2026
yahoo.com
Journey Medical Corporation to Announce First Quarter 2026 Financial Results on May 13, 2026
06-05-2026
yahoo.com
Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
13-05-2026
yahoo.com
Fortress Biotech Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
14-05-2026
yahoo.com
Fortress Biotech to Participate in A.G.P.’s Annual Virtual Healthcare Conference
18-05-2026
yahoo.com
What is the current price of FORTRESS BIOTECH INC - FBIO 9 3/8 PERP (FBIOP:NASDAQ)?
The current price of FORTRESS BIOTECH INC - FBIO 9 3/8 PERP (FBIOP:NASDAQ) is $20.71.
FORTRESS BIOTECH INC - FBIO 9 3/8 PERP (FBIOP:NASDAQ) absolute price change since previous trading day?
The absolute price change of FORTRESS BIOTECH INC - FBIO 9 3/8 PERP (FBIOP:NASDAQ) since the previous trading day is $0.21.
FORTRESS BIOTECH INC - FBIO 9 3/8 PERP (FBIOP:NASDAQ) percentage price change since previous trading day?
The percentage price change of FORTRESS BIOTECH INC - FBIO 9 3/8 PERP (FBIOP:NASDAQ) since the previous trading day is 1.0244%.
What is the most recent average sentiment score for FORTRESS BIOTECH INC - FBIO 9 3/8 PERP (FBIOP:NASDAQ)?
The most recent average sentiment score for FORTRESS BIOTECH INC - FBIO 9 3/8 PERP (FBIOP:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for FORTRESS BIOTECH INC - FBIO 9 3/8 PERP (FBIOP:NASDAQ)?
The most recent sentiment for FORTRESS BIOTECH INC - FBIO 9 3/8 PERP (FBIOP:NASDAQ) is .
SEC-8K** Filing Available For FORTRESS BIOTECH INC - FBIO 9 3/8 PERP (FBIOP:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.